Peer-reviewedCC BYFrontiers in endocrinology
Continuous glucose monitoring after discontinuation of incretin-based obesity pharmacotherapy: indirect evidence and a research framework for metabolic stability and weight maintenance
- 1Department of Endocrinology and Diabetology, University Medical Center Maribor , ,
- 2Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana , ,
Related
- Precision Pharmacotherapy for Childhood Obesity: Molecular Targets Beyond Single GLP-1 Receptor Agonism and a Framework for Disease Modification
- Knowledge, attitude and practice on continuous glucose monitoring and self-monitoring of blood glucose among healthcare professionals across India: A cross-sectional study
- Age-Stratified Median Effective Dose of a Continuous Remimazolam Maintenance Infusion for Moderate Sedation During Spinal Anesthesia: A Prospective Up-and-Down Dose-Finding Study.
- Continuous Glucose Monitoring for Metabolic Phenotyping and Precision Nutrition: Current Evidence, Clinical Applications and Future Perspectives
- Intraoperative Neurophysiological Monitoring During Continuous Radiofrequency Treatment of Morton’s Neuroma: Complete Ablation
BibTeX
@article{koceva2026continuous,
title = {{Continuous glucose monitoring after discontinuation of incretin-based obesity pharmacotherapy: indirect evidence and a research framework for metabolic stability and weight maintenance}},
author = {Andrijana Koceva and Andrej Janez and Mojca Jensterle},
journal = {Frontiers in endocrinology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13656005},
note = {CC BY},
}
RIS
TY - JOUR
TI - Continuous glucose monitoring after discontinuation of incretin-based obesity pharmacotherapy: indirect evidence and a research framework for metabolic stability and weight maintenance
AU - Andrijana Koceva
AU - Andrej Janez
AU - Mojca Jensterle
PY - 2026
DA - 2026/10/16
JO - Frontiers in endocrinology
UR - https://europepmc.org/article/PMC/PMC13656005
SN - 1664-2392
ER -